Authors
Dr. Rema MN, MD, Professor & HOD, Department of Pharmacology, Amala Institute of Medical Science; President, TC Medical Council
Abstract
Introduction: The inevitable consequence of the widespread use of antimicrobial agents has been the emergence of antibiotic-resistant pathogens, fueling an ever-increasing need for new antimicrobial agents.
Methodology: The clinical use and therapeutic effects of the new drug Tigecycline is described.
Result: Tigecycline is an example of a new drug developed in response to the growing prevalence of antibiotic resistance in bacteria such as Staphylococcus aureus. It was approved by FDA in 2005